Department of Medical Research, Cathay General Hospital, Taipei 10630, Taiwan.
Program in Pharmaceutical Biotechnology, College of Medicine, Fu Jen Catholic University, New Taipei City 24205, Taiwan.
Int J Mol Sci. 2021 Jun 4;22(11):6078. doi: 10.3390/ijms22116078.
Skin barrier functions, environmental insults, and genetic backgrounds are intricately linked and form the basis of common inflammatory skin disorders, such as atopic dermatitis, psoriasis, and seborrheic dermatitis, which may seriously affect one's quality of life. Topical therapy is usually the first line of management. It is believed that successful topical treatment requires pharmaceutical formulation from a sufficient dosage to exert therapeutic effects by penetrating the stratum corneum and then diffusing to the target area. However, many factors can affect this process including the physicochemical properties of the active compound, the composition of the formulation base, and the limitations and conditions of the skin barrier, especially in inflammatory skin. This article briefly reviews the available data on these issues and provides opinions on strategies to develop a suitable formulation for inflammatory skin disease treatment.
皮肤屏障功能、环境刺激物和遗传背景错综复杂地相互关联,构成了常见炎症性皮肤病(如特应性皮炎、银屑病和脂溢性皮炎)的基础,这些疾病可能严重影响人们的生活质量。局部治疗通常是一线治疗方法。人们认为,成功的局部治疗需要药物制剂具有足够的剂量,通过穿透角质层发挥治疗作用,然后扩散到目标区域。然而,许多因素会影响这一过程,包括活性化合物的物理化学性质、制剂基质的组成以及皮肤屏障的限制和条件,特别是在炎症性皮肤中。本文简要回顾了这些问题的现有数据,并就开发适合炎症性皮肤病治疗的制剂策略提供了意见。